Last updated: February 6, 2026
Sponsor: University of Arizona
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Speech Disorders
Communication Disorders
Treatment
Enhanced Conversational Recast treatment
Clinical Study ID
NCT06250101
DLD-Tx2
Ages 48-83 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Language scores consistent with a developmental language disorder nonverbal cognitive scores consistent with normal-range intellectual functioning
Exclusion
Exclusion Criteria:
hearing loss Intellectual disability Other handicapping conditions
Study Design
Total Participants: 24
Treatment Group(s): 1
Primary Treatment: Enhanced Conversational Recast treatment
Phase:
Study Start date:
June 17, 2024
Estimated Completion Date:
October 30, 2026
Study Description
Connect with a study center
The University of Arizona
Tucson, Arizona 85721
United StatesSite Not Available
The University of Arizona
Tucson 5318313, Arizona 5551752 85721
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.